Interestingly, Otvos et al. developed a new adiponectin-based short peptide (H-DAsn-Ile-Pro-Nva-Leu-Tyr-DSer-Phe-Ala-DSer-NH2) named ADP 355, which could be suitable for treatment in cancer. Here, ADIPOQ is linked to cancer.